[1] Lyu J, Xie YM, Sun MH, et al.Clinical evidence and GRADE assessment for breviscapine injection (DengZhanHuaSu) in patients with acute cerebral infarction[J]. Journal of Ethnopharmacology, 2020(4): 262-265. [2] Wu LH, Gao YH, Zhang SF, et al.The effects of breviscapine injection on hypertension in hypertension-induced renal damage patients: a systematic review and a meta-analysis[J]. Frontiers in Pharmacology, 2019, 10: 118-122. [3] Yan ZL, Zhi YL, Xiao HL, et al.Effect of breviscapine against hepatic ischemia reperfusion injury[J]. Journal of Surgical Research, 2016, 203(2): 268-274. [4] Gao JL, Chen G, He HQ, et al.Therapeutic effects of breviscapine in cardiovascular diseases: a review[J]. Front Pharmacol, 2017, 8: 289. [5] Li YY, Guo RJ, Xie YM, et al.Expert consensus on clinical application of breviscapine for injection[J]. China Journal of Traditi-onal Chinese Medicine(中国中药杂志), 2020, 45(10): 2296-2299. [6] Baumfeld AE, Reynolds Robert, Caubel P, et al.Trial designs using real-world data: The changing landscape of the regulatory approval process[J]. Pharmacoepidemiol Drug Saf, 2020, 29: 1201-1212. [7] World Health Organization.International Statistical Classification of Diseases and Related Health Issues (10th Revision)[M]. 2nd Ed. Beijing: People's Medical Publishing House(国际疾病标准编码), 2008. [8] Yaozhi Data.Drug ATC code query system [EB/OL]. [2021-05-10].https://db.yaozh.com/atc/. [9] Schwartz JB, Schmader KE, Hanlon JT, et al.Pharmacotherapy in older adults with cardiovascular disease: report from an american college of cardiology, american geriatrics society, and national institute on aging workshop[J]. J Am Geriatr Soc, 2019, 67: 371-380. [10] Liu X, Guo CY, Ma XJ, et al.Relationship between serum estrogen levels and blood stasis syndrome in postmenopausal women with coronary heart disease[J]. Pak J Med Sci, 2015, 31: 25-30. [11] Zhang AZ. Traditional Chinese Orthopedics(中医骨伤学) [M].Shanghai: Shanghai Science and Technology Press, 1997: 33. [12] Liao CZ.Breviscapine in the treatment of 45 cases of knee osteoar-thritis[J]. China Pharmaceutical(中国药业), 2015, 24(8): 88-89. [13] Jin R, Wang YG, Xue CM, et al.Criterion and scale exploration of Chinese patent medicine prescription comment(4): indication inappropriateness[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2015, 35(13): 1161-1167. [14] Pan ZW, Feng TM, Shan LC, et al.Scutellarin-induced endoth-elium-independent relaxation in rataorta[J]. Phytother Res, 2008, 22: 1428-1433. [15] Wang Y, Fan LP, Song J, et al.Analysis and discussion on 74 cases of adverse reactions of TCM injection[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2018, 43(21): 4347-4351 [16] Cheng FJM, Xie YM, Wang LX, et al.Real-world study of the factors influencing suspected anaphylaxis of breviscapine for injection[J]. Journal of Traditional Chinese Medicine(中医杂志), 2020, 61(24): 2174-2178. [17] Arnett DK, Blumenthal RS, Albert MA, et al.2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology/american heart association task force on clinical practice guidelines[J]. J Am Coll Cardiol, 2019, 74: e177-e232. [18] Mo C, Sun G, Wang YZ, et al.PPI versus histamine h2 receptor antagonists for prevention of upper gastrointestinal injury associated with low-dose aspirin: systematic review and meta-analysis[J]. PLoS One, 2015, 10: e0131558. [19] Salmoirago-Blotcher E, Crawford S, Jackson E, et al.Constipation and risk of cardiovascular disease among postmenopausal women[J]. Am J Med, 2011, 124: 714-23. [20] Ruan XF, Li YJ, Ju CW, et al.Exosomes from Suxiao Jiuxin pill-treated cardiac mesenchymal stem cells decrease H3K27 demethylase UTX expression in mouse cardiomyocytes in vitro[J].Acta Pharmacol Sin, 2018, 39: 579-586. [21] Lu DP, Wang YM, Yin KZ, et al.Analysis and utilization of 2011 annual report of adverse drug reaction monitoring[J]. China Pharmaceutical(中国药业), 2012, 21(22): 7-8. |